Hidenori Fukuoka
Overview
Explore the profile of Hidenori Fukuoka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
1288
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fukuoka H
Endocr J
. 2025 Mar;
PMID: 40058819
Cushing's disease is a rare endocrine disorder that presents many systemic complications, and its initial phase management can be difficult in atypical and severe cases or at institutes with limited...
2.
Fukuoka H, Endo T, Tsuboi S, Fujio S
Pituitary
. 2025 Feb;
28(2):32.
PMID: 39966200
Purpose: Adult growth hormone deficiency (AGHD) increases the prevalence of complications, including metabolic disorder, leading to increased cardiovascular mortality from cardiovascular diseases. However, no large database studies have evaluated AGHD...
3.
Nishikage S, Yamamoto M, Niikura T, Inaba Y, Akiyama T, Harada R, et al.
Endocr J
. 2025 Jan;
PMID: 39880615
The use of asfotase alfa, a bone-targeted recombinant alkaline phosphatase (ALP) enzyme, for the treatment of adult-onset hypophosphatasia (HPP) remains controversial, particularly in patients without evident bone abnormalities. We report...
4.
Tsujimoto Y, Yamamoto N, Bando H, Yamamoto M, Ohmachi Y, Motomura Y, et al.
Front Endocrinol (Lausanne)
. 2025 Jan;
15():1511155.
PMID: 39764253
Metyrapone is commonly used in the initial management of Cushing's syndrome to reduce hypercortisolemia, but its optimal dosage and timing can vary significantly between patients. Currently, there are limited guidelines...
5.
Urai S, Bando H, Nakatsuji M, Yamamoto M, Fukuoka H, Iguchi G, et al.
Endocrinol Diabetes Metab Case Rep
. 2024 Sep;
2024(3).
PMID: 39299274
Summary: A 52-year-old female patient with breast cancer presented with a history of fatigue and malaise 1 year prior. She was diagnosed with isolated adrenocorticotropic hormone (ACTH) deficiency (IAD) on...
6.
Oi-Yo Y, Yamamoto M, Urai S, Bando H, Ohmachi Y, Motomura Y, et al.
Pituitary
. 2024 Sep;
27(5):605-613.
PMID: 39298061
Purpose: To elucidate the long-term efficacy and safety of growth hormone replacement therapy (GHRT) in Japanese patients with adult growth hormone deficiency (AGHD). Methods: We conducted a retrospective study. A...
7.
8.
Ichinose Y, Nakatsuji M, Bando H, Yamamoto M, Kanzawa M, Yoshino K, et al.
J Neuroendocrinol
. 2024 Aug;
36(11):e13438.
PMID: 39136082
Cushing's syndrome is characterized by chronic glucocorticoid oversecretion and diverse clinical manifestations. Distinguishing between adrenocorticotropic hormone (ACTH)-independent and ACTH-dependent forms is crucial for determining treatment options. Plasma ACTH levels aid...
9.
Motomura Y, Urai S, Bando H, Yamamoto M, Suzuki M, Yamamoto N, et al.
Endocrine
. 2024 Jul;
86(1):417-427.
PMID: 39037671
Purpose: Early diagnosis and immediate treatment of Cushing's syndrome (CS) are critical for a better prognosis but remain a challenge. However, few comprehensive reports have focused on this issue or...
10.
Urai S, Tomofuji S, Bando H, Kanzawa M, Yamamoto M, Fukuoka H, et al.
J Neuroendocrinol
. 2024 Apr;
36(6):e13395.
PMID: 38631695
Anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis, a paraneoplastic syndrome resulting from an autoimmune response against PIT-1, typically manifests with undetectable levels of growth hormone (GH) and prolactin (PRL), and significantly low...